Takeda Pharmaceutical Company Ltd
- Country
- 🇸🇪Sweden
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
A Study About Fazirsiran in People With and Without Liver Problems
- First Posted Date
- 2023-06-06
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Takeda
- Target Recruit Count
- 41
- Registration Number
- NCT05891158
- Locations
- 🇸🇰
Summit Clinical Research s.r.o., Nove Zamky, Slovakia
🇭🇺CRU Hungary Kft, Kistarcsa, Hungary
A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia
- First Posted Date
- 2023-06-02
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Takeda
- Target Recruit Count
- 53
- Registration Number
- NCT05886491
- Locations
- 🇺🇸
Tri-Star BMT/Sarah Cannon Nashville, Nashville, Tennessee, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, United States
A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin
- First Posted Date
- 2023-06-02
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Takeda
- Target Recruit Count
- 26
- Registration Number
- NCT05886478
- Locations
- 🇩🇪
Universitätsmedizin Göttingen, Göttingen, Germany
🇫🇷Hopital Saint Andre, Bordeaux, France
🇫🇷Hopital Saint Louis, Paris, France
A Survey on NINLARO Risk Management Plan (RMP) Material Utilization Among Pharmacists in Japan
- Conditions
- Multiple Myeloma
- Interventions
- Other: No Intervention
- First Posted Date
- 2023-05-31
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- Takeda
- Target Recruit Count
- 330
- Registration Number
- NCT05882279
- Locations
- 🇯🇵
Takeda selected site, Tokyo, Japan
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
- Conditions
- Multiple MyelomaSecondary Immunodeficiency (SID)
- Interventions
- Other: No Intervention
- First Posted Date
- 2023-05-30
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Takeda
- Target Recruit Count
- 100
- Registration Number
- NCT05879757
- Locations
- 🇦🇷
Instituto Privado de Investigaciones Clinicas de Cordoba, Cordoba, Argentina
🇨🇿Fakultni nemocnice Plzen, Pilsen, Czechia
🇨🇿Vseobecna fakultni Nemocnice, Prague, Czechia
A Real World Study of Mobocertinib in Adults With Lung Cancer in China (MEANING)
- Conditions
- Non-small Cell Lung Cancer (NSCLC)
- Interventions
- Other: No Intervention
- First Posted Date
- 2023-05-18
- Last Posted Date
- 2023-10-18
- Lead Sponsor
- Takeda
- Registration Number
- NCT05863819
- Locations
- 🇨🇳
Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiaotong University, P. R. China, Shanghai, China
A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease
- First Posted Date
- 2023-05-01
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Takeda
- Target Recruit Count
- 408
- Registration Number
- NCT05837897
- Locations
- 🇨🇳
Guangzhou First People's Hospital, Guangzhou, Guangdong, China
🇨🇳The Second Hospital of Anhui Medical University, Hefei, Anhui, China
🇨🇳Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China
A Study of TAK-227 in Healthy Adults
- Conditions
- Healthy Volunteers
- Interventions
- Drug: TAK-227
- First Posted Date
- 2023-04-19
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Takeda
- Target Recruit Count
- 24
- Registration Number
- NCT05818956
- Locations
- 🇺🇸
Celerion, Inc., Tempe, Arizona, United States
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
- Conditions
- Narcolepsy Type 1
- Interventions
- Drug: TAK-861
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Takeda
- Target Recruit Count
- 500
- Registration Number
- NCT05816382
- Locations
- 🇩🇪
Somni Bene Institut fur Medizinische Forschung und Schlafmedizin Schwerin GmbH, Schwerin, Mecklenburg-Vorpommern, Germany
🇮🇹Fondazione PTV Policlinico Tor Vergata, Roma, Lazio, Italy
🇳🇴University of Oslo, Oslo, Norway
A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery
- First Posted Date
- 2023-04-14
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Takeda
- Target Recruit Count
- 41
- Registration Number
- NCT05814016
- Locations
- 🇺🇸
Helen Keller Hospital, Sheffield, Alabama, United States
🇺🇸Mayo Clinic - PPDS - Hospital, Phoenix, Arizona, United States
🇺🇸UCSD, La Jolla, California, United States